In Silico Design and Validation of CRISPR-Cas13a System as a Potential Antiviral for SARS-CoV-2 in Indonesia. Nusantara Science and Technology Proceedings, Malang, Indonesia, p. 44–51, 2022. DOI: 10.11594/nstp.2022.2107. Disponível em: https://nstproceeding.com/index.php/nuscientech/article/view/628. Acesso em: 24 apr. 2025.